Central Florida Cancer Institute is categorized under Internal Medicine Doctors in Kissimmee, FL and active since 2008.
Central Florida Cancer Institute was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Reginald Allen at the company’s single location by writing to 4551 Pleasant Hill Road, Kissimmee, Florida FL 34759 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Cancer Institute |
| Contact Person: | Reginald Allen |
| Address: | 4551 Pleasant Hill Road, Kissimmee, Florida 34759 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Central Florida Cancer Institute was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Reginald Allen for inquiries that concern Central Florida Cancer Institute by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Florida Cancer Institute can be found at the coordinates 28.150339,-81.441148 as well as the street address 4551 Pleasant Hill Road in Kissimmee, Florida 34759.
For its online presence, you may visit Central Florida Cancer Institute’s website at and engage with its social media outlets through on Twitter and on Facebook.